Travere Therapeutics’ share price has been climbing as investors respond to upbeat analyst sentiment and growing optimism around the company’s outlook, even in a tough healthcare market. Analysts have reiterated their Buy recommendations on the stock, and the latest price targets still point to meaningful upside from current levels, reinforcing the bullish case for Travere among market watchers.
https://www.tipranks.com/news/catalyst/travere-therapeutics-shares-surge-on-bullish-analyst-calls
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.